Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 711

1.

Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination.

Yamashita S, Arai H, Yokote K, Araki E, Matsushita M, Nojima T, Suganami H, Ishibashi S.

Int J Mol Sci. 2019 Nov 6;20(22). pii: E5537. doi: 10.3390/ijms20225537.

2.

Myeloid HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) Reductase Determines Adipose Tissue Inflammation, Insulin Resistance And Hepatic Steatosis In Diet-Induced Obese Mice.

Takei A, Nagashima S, Takei S, Yamamuro D, Murakami A, Wakabayashi T, Isoda M, Yamazaki H, Ebihara C, Takahashi M, Ebihara K, Ishibashi S.

Diabetes. 2019 Nov 5. pii: db190076. doi: 10.2337/db19-0076. [Epub ahead of print]

PMID:
31690648
3.

Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma.

Yamamoto K, Abe S, Honda A, Hashimoto J, Aizawa Y, Ishibashi S, Takemura T, Hanagata N, Yamamoto M, Miura O, Kurata M, Kitagawa M.

Lab Invest. 2019 Sep 16. doi: 10.1038/s41374-019-0318-6. [Epub ahead of print]

PMID:
31527828
4.

Prevalence of antimicrobial-resistant Escherichia coli in endangered Okinawa rail (Gallirallus okinawae) inhabiting areas around a livestock farm.

Ishibashi S, Sumiyama D, Kanazawa T, Murata K.

Vet Med Sci. 2019 Aug 26. doi: 10.1002/vms3.194. [Epub ahead of print]

5.

Case of acute-onset type 1 diabetes induced by long-term immunotherapy with nivolumab in a patient with mucosal melanoma.

Maekawa T, Okada K, Okada H, Kado S, Kamiya K, Komine M, Murata S, Oka K, Ishibashi S, Ohtsuki M.

J Dermatol. 2019 Aug 22. doi: 10.1111/1346-8138.15061. [Epub ahead of print] No abstract available.

PMID:
31436330
6.

Computational study of positron annihilation parameters for cation mono-vacancies and vacancy complexes in nitride semiconductor alloys.

Ishibashi S, Uedono A, Kino H, Miyake T, Terakura K.

J Phys Condens Matter. 2019 Nov 27;31(47):475401. doi: 10.1088/1361-648X/ab35a4. Epub 2019 Aug 20.

PMID:
31429422
7.

Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis.

Nishida Y, Takahashi YK, Kanai T, Nose Y, Ishibashi S, Sanjo N, Uzawa A, Oda F, Ozawa Y, Kuwabara S, Noguchi E, Suzuki S, Nakahara J, Suzuki N, Ogawa T, Yokoyama K, Hattori N, Konno S, Fujioka T, Kawaguchi N, Hatanaka Y, Sonoo M, Kaneko J, Ogino M, Nishiyama K, Nomura K, Yokota T.

Eur J Neurol. 2019 Jul 15. doi: 10.1111/ene.14039. [Epub ahead of print]

PMID:
31309642
8.

Low hemoglobin A1c and low body mass index are associated with dementia and activities of daily living disability among Japanese nursing home residents with diabetes.

Hatano Y, Araki A, Matsumoto M, Ishibashi S.

Geriatr Gerontol Int. 2019 Sep;19(9):854-860. doi: 10.1111/ggi.13728. Epub 2019 Jun 30.

PMID:
31257696
9.

Intrathecal IgG Synthesis and Persistent Inflammation Are Associated with White Matter Lesions in HIV-negative Patients with Cryptococcal Meningoencephalitis.

Ohyagi M, Irioka T, Ohkubo T, Ishibashi S, Takahashi YK, Amano E, Machida A, Kuwahara H, Yokota T.

Intern Med. 2019 Nov 1;58(21):3077-3082. doi: 10.2169/internalmedicine.2338-18. Epub 2019 Jun 27.

10.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P.

Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Review.

11.

First-principles studies of spin-orbital physics in pyrochlore oxides.

Shinaoka H, Motome Y, Miyake T, Ishibashi S, Werner P.

J Phys Condens Matter. 2019 Aug 14;31(32):323001. doi: 10.1088/1361-648X/ab162f. Epub 2019 May 29.

PMID:
31140447
12.

Elevated lipid peaks during the recovery phase of Baló's concentric sclerosis: A case report.

Otsu S, Ishibashi S, Ozaki K, Yokota T.

eNeurologicalSci. 2019 Apr 9;15:100191. doi: 10.1016/j.ensci.2019.100191. eCollection 2019 Jun. No abstract available.

13.

Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation.

Guo L, Bertola DR, Takanohashi A, Saito A, Segawa Y, Yokota T, Ishibashi S, Nishida Y, Yamamoto GL, Franco JFDS, Honjo RS, Kim CA, Musso CM, Timmons M, Pizzino A, Taft RJ, Lajoie B, Knight MA, Fischbeck KH, Singleton AB, Ferreira CR, Wang Z, Yan L, Garbern JY, Simsek-Kiper PO, Ohashi H, Robey PG, Boyde A, Matsumoto N, Miyake N, Spranger J, Schiffmann R, Vanderver A, Nishimura G, Passos-Bueno MRDS, Simons C, Ishikawa K, Ikegawa S.

Am J Hum Genet. 2019 May 2;104(5):925-935. doi: 10.1016/j.ajhg.2019.03.004. Epub 2019 Apr 11.

14.

Cortical bone response toward nanosecond-pulsed laser-treated zirconia implant surfaces.

Hirota M, Harai T, Ishibashi S, Mizutani M, Hayakawa T.

Dent Mater J. 2019 Jun 1;38(3):444-451. doi: 10.4012/dmj.2018-153. Epub 2019 Mar 26.

15.

Scrotal hematoma following femoral artery puncture.

Ishibashi S, Sakakura K, Yamamoto K, Okochi T, Momomura SI, Fujita H.

Clin Case Rep. 2019 Jan 8;7(2):391-393. doi: 10.1002/ccr3.1995. eCollection 2019 Feb.

16.

Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52-week data from the PROVIDE study.

Araki E, Yamashita S, Arai H, Yokote K, Satoh J, Inoguchi T, Nakamura J, Maegawa H, Yoshioka N, Tanizawa Y, Watada H, Suganami H, Ishibashi S.

Diabetes Obes Metab. 2019 Jul;21(7):1737-1744. doi: 10.1111/dom.13686. Epub 2019 Apr 1.

17.

Mondor's Disease.

Ito H, Ishibashi S, Kaburagi T.

Intern Med. 2019 Jun 15;58(12):1805. doi: 10.2169/internalmedicine.2024-18. Epub 2019 Feb 25. No abstract available.

18.

Single-component molecular conductor [Pt(dmdt)2]-a three-dimensional ambient-pressure molecular Dirac electron system.

Zhou B, Ishibashi S, Ishii T, Sekine T, Takehara R, Miyagawa K, Kanoda K, Nishibori E, Kobayashi A.

Chem Commun (Camb). 2019 Mar 14;55(23):3327-3330. doi: 10.1039/c9cc00218a.

PMID:
30741309
19.

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment.

Yokote K, Yamashita S, Arai H, Araki E, Suganami H, Ishibashi S, Of The K-Study Group OB.

Int J Mol Sci. 2019 Feb 6;20(3). pii: E706. doi: 10.3390/ijms20030706.

20.

Zebrafish duox mutations provide a model for human congenital hypothyroidism.

Chopra K, Ishibashi S, Amaya E.

Biol Open. 2019 Feb 22;8(2). pii: bio037655. doi: 10.1242/bio.037655.

21.

Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency.

Takanashi M, Kimura T, Li C, Tanaka M, Matsuhashi A, Yoshida H, Noda A, Xu P, Takase S, Okazaki S, Iizuka Y, Kumagai H, Ikeda Y, Gotoda T, Takahashi M, Yagyu H, Ishibashi S, Yamauchi T, Kadowaki T, Liang G, Okazaki H.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):373-386. doi: 10.1161/ATVBAHA.118.311931.

PMID:
30700132
22.

Remarkable improvement in progressive multifocal leukoencephalopathy following acute pyelonephritis with bacteremia.

Amano E, Ozaki K, Ishibashi S, Sanjo N, Yokota T.

J Clin Neurosci. 2019 Apr;62:226-228. doi: 10.1016/j.jocn.2018.12.034. Epub 2019 Jan 3.

PMID:
30612916
23.

Effects of propofol versus sevoflurane on cerebral circulation time in patients undergoing coiling for cerebral artery aneurysm: a prospective randomized crossover study.

Ishibashi T, Toyama S, Miki K, Karakama J, Yoshino Y, Ishibashi S, Tomita M, Nemoto S.

J Clin Monit Comput. 2019 Dec;33(6):987-998. doi: 10.1007/s10877-018-00251-2. Epub 2019 Jan 4.

PMID:
30610516
24.

A pediatric case with parvovirus B19-associated uveitis without autoantibody formation.

Ito T, Hoshina T, Mizuki K, Fukuda T, Ishibashi S, Kusuhara K.

Nagoya J Med Sci. 2018 Nov;80(4):611-614. doi: 10.18999/nagjms.80.4.611.

25.

Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Obes Metab. 2018 Nov 4. doi: 10.1111/dom.13575. [Epub ahead of print]

26.

Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages.

Sakai K, Nagashima S, Wakabayashi T, Tumenbayar B, Hayakawa H, Hayakawa M, Karasawa T, Ohashi K, Yamazaki H, Takei A, Takei S, Yamamuro D, Takahashi M, Yagyu H, Osuga JI, Takahashi M, Tominaga SI, Ishibashi S.

Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2590-2600. doi: 10.1161/ATVBAHA.118.311664.

PMID:
30354246
27.

Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.

Wakabayashi T, Takahashi M, Yamamuro D, Karasawa T, Takei A, Takei S, Yamazaki H, Nagashima S, Ebihara K, Takahashi M, Ishibashi S.

Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2576-2589. doi: 10.1161/ATVBAHA.118.311648.

PMID:
30354239
28.

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.

Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM.

Am Heart J. 2018 Dec;206:80-93. doi: 10.1016/j.ahj.2018.09.011. Epub 2018 Sep 29. Review.

29.

Loss of ACAT1 Attenuates Atherosclerosis Aggravated by Loss of NCEH1 in Bone Marrow-Derived Cells.

Yamazaki H, Takahashi M, Wakabayashi T, Sakai K, Yamamuro D, Takei A, Takei S, Nagashima S, Yagyu H, Sekiya M, Ebihara K, Ishibashi S.

J Atheroscler Thromb. 2019 Mar 1;26(3):246-259. doi: 10.5551/jat.44040. Epub 2018 Oct 4.

30.

Correction to: Effect of simultaneous exposure to extremely short pulses of blue and green light on human pupillary constriction.

Lee S, Ishibashi S, Shimomura Y, Katsuura T.

J Physiol Anthropol. 2018 Aug 30;37(1):21. doi: 10.1186/s40101-018-0180-z.

31.

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S; Committee for Epidemiology and Clinical Management of Atherosclerosis.

J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22. No abstract available.

32.

Levodopa-responsive truncal tremor in a patient with spinocerebellar ataxia type 3.

Miura M, Numasawa Y, Takahisa M, Ozaki K, Irioka T, Nishida Y, Ishibashi S, Yokota T.

J Neurol Sci. 2018 Sep 15;392:32-33. doi: 10.1016/j.jns.2018.06.023. Epub 2018 Jun 28. No abstract available.

PMID:
30097150
33.

Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia.

Yamashita S, Arai H, Yokote K, Araki E, Suganami H, Ishibashi S; K-877 Study Group.

J Clin Lipidol. 2018 Sep - Oct;12(5):1267-1279.e4. doi: 10.1016/j.jacl.2018.06.010. Epub 2018 Jun 26.

34.

Progressive Encephalomyelitis with Rigidity and Myoclonus Resolving after Thymectomy with Subsequent Anasarca: An Autopsy Case.

Ozaki K, Ohkubo T, Yamada T, Yoshioka K, Ichijo M, Majima T, Kudo S, Akashi T, Honda K, Ito E, Watanabe M, Sekine M, Hamagaki M, Eishi Y, Sanjo N, Ishibashi S, Mizusawa H, Yokota T.

Intern Med. 2018 Dec 1;57(23):3451-3458. doi: 10.2169/internalmedicine.1238-18. Epub 2018 Jul 6.

35.

Hepato-entrained B220+CD11c+NK1.1+ cells regulate pre-metastatic niche formation in the lung.

Hiratsuka S, Tomita T, Mishima T, Matsunaga Y, Omori T, Ishibashi S, Yamaguchi S, Hosogane T, Watarai H, Omori-Miyake M, Yamamoto T, Shibata N, Watanabe A, Aburatani H, Tomura M, High KA, Maru Y.

EMBO Mol Med. 2018 Jul;10(7). pii: e8643. doi: 10.15252/emmm.201708643.

36.

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017.

Harada-Shiba M, Arai H, Ishigaki Y, Ishibashi S, Okamura T, Ogura M, Dobashi K, Nohara A, Bujo H, Miyauchi K, Yamashita S, Yokote K; Working Group by Japan Atherosclerosis Society for Making Guidance of Familial Hypercholesterolemia.

J Atheroscler Thromb. 2018 Aug 1;25(8):751-770. doi: 10.5551/jat.CR003. Epub 2018 Jun 7.

37.

A multi-institutional study of secondary check of treatment planning using Clarkson-based dose calculation for three-dimensional radiotherapy.

Takahashi R, Kamima T, Itano M, Yamazaki T, Ishibashi S, Higuchi Y, Shimizu H, Yamamoto T, Yamashita M, Baba H, Sugawara Y, Sato A, Nishiyama S, Kawai D, Miyaoka S, Tachibana H.

Phys Med. 2018 May;49:19-27. doi: 10.1016/j.ejmp.2018.04.394. Epub 2018 Apr 25.

PMID:
29866338
38.

A multi-institutional study of independent calculation verification in inhomogeneous media using a simple and effective method of heterogeneity correction integrated with the Clarkson method.

Jinno S, Tachibana H, Moriya S, Mizuno N, Takahashi R, Kamima T, Ishibashi S, Sato M.

J Radiat Res. 2018 Jul 1;59(4):490-500. doi: 10.1093/jrr/rry039.

39.

Springtime photoinhibition constrains regeneration of forest floor seedlings of Abies sachalinensis after a removal of canopy trees during winter.

Kitao M, Harayama H, Han Q, Agathokleous E, Uemura A, Furuya N, Ishibashi S.

Sci Rep. 2018 Apr 20;8(1):6310. doi: 10.1038/s41598-018-24711-6.

40.

A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement.

Ando A, Nagasaka S, Ishibashi S.

Endocrinol Diabetes Metab Case Rep. 2018 Apr 11;2018. pii: 18-0005. doi: 10.1530/EDM-18-0005. eCollection 2018.

41.

Strong polarization switching with low-energy loss in hydrogen-bonded organic antiferroelectrics.

Horiuchi S, Kumai R, Ishibashi S.

Chem Sci. 2017 Nov 1;9(2):425-432. doi: 10.1039/c7sc03859c. eCollection 2018 Jan 14.

42.

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial.

Arai H, Yamashita S, Yokote K, Araki E, Suganami H, Ishibashi S; K-877 Study Group.

J Atheroscler Thromb. 2018 Jun 1;25(6):521-538. doi: 10.5551/jat.44412. Epub 2018 Apr 7.

43.

Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Care. 2018 Jun;41(6):1275-1284. doi: 10.2337/dc17-2224. Epub 2018 Apr 6.

PMID:
29626074
44.

Effects of a novel selective peroxisome proliferator-activated receptor-α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance.

Matsuba I, Matsuba R, Ishibashi S, Yamashita S, Arai H, Yokote K, Suganami H, Araki E.

J Diabetes Investig. 2018 Nov;9(6):1323-1332. doi: 10.1111/jdi.12845. Epub 2018 Apr 26.

45.

Weaning stage hyperglycemia induces glucose-insensitivity in arcuate POMC neurons and hyperphagia in type 2 diabetic GK rats.

Ando A, Gantulga D, Nakata M, Maekawa F, Dezaki K, Ishibashi S, Yada T.

Neuropeptides. 2018 Apr;68:49-56. doi: 10.1016/j.npep.2018.02.001. Epub 2018 Feb 6.

46.

Dynamic spinal compression revealed by computed tomography myelography in overshunting-associated myelopathy: A case report.

Amano E, Ozaki K, Egawa S, Suzuki M, Hirai T, Ishibashi S, Ohkubo T, Yoshii T, Okawa A, Yokota T.

Medicine (Baltimore). 2018 Mar;97(10):e0082. doi: 10.1097/MD.0000000000010082.

47.

A case of severe neonatal asphyxia due to umbilical artery thrombosis.

Kitano T, Ohgitani A, Takagi K, Arai I, Yasuhara H, Ebisu R, Takeda Y, Ishibashi S, Morita K, Minowa H.

J Obstet Gynaecol. 2018 Nov;38(8):1164-1165. doi: 10.1080/01443615.2017.1404012. Epub 2018 Mar 7. No abstract available.

PMID:
29514532
48.

Field-Induced Antipolar-Polar Structural Transformation and Giant Electrostriction in Organic Crystal.

Kobayashi K, Horiuchi S, Ishibashi S, Murakami Y, Kumai R.

J Am Chem Soc. 2018 Mar 21;140(11):3842-3845. doi: 10.1021/jacs.7b13688. Epub 2018 Mar 9.

PMID:
29505710
49.

Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma.

Kinowaki Y, Kurata M, Ishibashi S, Ikeda M, Tatsuzawa A, Yamamoto M, Miura O, Kitagawa M, Yamamoto K.

Lab Invest. 2018 May;98(5):609-619. doi: 10.1038/s41374-017-0008-1. Epub 2018 Feb 20.

50.

Sphingosine-1-Phosphate Receptor 1 Activation Enhances Leptomeningeal Collateral Development and Improves Outcome after Stroke in Mice.

Iwasawa E, Ishibashi S, Suzuki M, Li F, Ichijo M, Miki K, Yokota T.

J Stroke Cerebrovasc Dis. 2018 May;27(5):1237-1251. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.040. Epub 2018 Jan 11.

PMID:
29337049

Supplemental Content

Loading ...
Support Center